Albumin-Bound Paclitaxel: all 674 studies that test it

Page 3 of 7. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.

• QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyTerminatedNCT03387098Phase 1/2Results posted
• QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.TerminatedNCT03387085Phase 1/2Results posted
• Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic CancerTerminatedNCT03344172Phase 2Results posted
• A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic CancerCompletedNCT03336216Phase 2Results posted
• QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyTerminatedNCT03329248Phase 1/2Results posted
• FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction AdenocarcinomaCompletedNCT03283761Phase 2Results posted
• Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial CancerCompletedNCT03240016Phase 2Results posted
• A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)CompletedNCT03193190Phase 1/2Results posted
• A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid TumorsCompletedNCT03184870Phase 1/2Results posted
• Pre-operative Treatment for Patients With Untreated Pancreatic CancerCompletedNCT03138720Phase 2Results posted
• QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyTerminatedNCT03136406Phase 1/2Results posted
• Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast CancerCompletedNCT03121352Phase 2Results posted
• Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck CancerCompletedNCT03107182Phase 2Results posted
• A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast CancerCompletedNCT02999477Phase 1Results posted
• A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung CancerTerminatedNCT02967133Phase 2Results posted
• Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory SarcomaCompletedNCT02945800Phase 2Results posted
• Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial CarcinomaTerminatedNCT02887248Phase 2Results posted
• A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic CancerCompletedNCT02873598Phase 1Results posted
• Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)CompletedNCT02819518Phase 3Results posted
• Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid TumorsCompletedNCT02810418Phase 1/2Results posted
• Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant MesotheliomaCompletedNCT02798536Phase 1Results posted
• Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell CancerCompletedNCT02769832Phase 2Results posted
• Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid TumorsCompletedNCT02762981Phase 1/2Results posted
• Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT02754726Phase 2Results posted
• Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast CancerActive, not recruitingNCT02752685Phase 2Results posted
• A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the UterusCompletedNCT02744898Phase 2Results posted
• Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic PatientsTerminatedNCT02732938Phase 2Results posted
• Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT02730247Phase 2Results posted
• Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular CorrelatesCompletedNCT02723331Phase 2Results posted
• Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLCCompletedNCT02716038Phase 2Results posted
• BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic CancerTerminatedNCT02608229Phase 1Results posted
• S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02562716Phase 2Results posted
• Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast CancerCompletedNCT02530489Phase 2Results posted
• Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung CancersCompletedNCT02525653Phase 2Results posted
• Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDACCompletedNCT02501902Phase 1Results posted
• PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal AdenocarcinomaTerminatedNCT02487277Phase 2Results posted
• Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02427841Phase 2Results posted
• Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary CancersCompletedNCT02392637Phase 2Results posted
• A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLCCompletedNCT02392507Phase 2Results posted
• BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast CancerCompletedNCT02379247Phase 1/2Results posted
• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]CompletedNCT02367794Phase 3Results posted
• LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL CancerCompletedNCT02328105Phase 2Results posted
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has SpreadTerminatedNCT02322814Phase 2Results posted
• Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal CancerCompletedNCT02317991Phase 2Results posted
• Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based ChemotherapyCompletedNCT02303977Phase 2Results posted
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)CompletedNCT02301143Phase 2Results posted
• Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT02289898Phase 2Results posted
• Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2CompletedNCT02289456Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02194829Phase 1/2Results posted
• Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With CholangiocarcinomaCompletedNCT02181634Phase 2Results posted
• Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic CancerCompletedNCT02178436Phase 1/2Results posted
• Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT02158520Phase 2Results posted
• Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the ElderlyCompletedNCT02151149Phase 4Results posted
• Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxelCompletedNCT02106884Phase 2Results posted
• Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal CancerCompletedNCT02103062Phase 2Results posted
• Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerCompletedNCT02077881Phase 1/2Results posted
• Treatment With Nab-paclitaxel in Cutaneous SCCTerminatedNCT02076243Phase 2Results posted
• Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple MyelomaTerminatedNCT02075021Phase 1/2Results posted
• Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With PaclitaxelCompletedNCT02073487Phase 2Results posted
• Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic CancerTerminatedNCT02047500Phase 1Results posted
• Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.CompletedNCT02033993Phase 2Results posted
• Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerCompletedNCT02027428Phase 3Results posted
• Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic CancerCompletedNCT02017015Phase 2Results posted
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)CompletedNCT01964430Phase 3Results posted
• Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsCompletedNCT01962103Phase 1/2Results posted
• Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerTerminatedNCT01938833Phase 1/2Results posted
• Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDACompletedNCT01893801Phase 1/2Results posted
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)CompletedNCT01881230Phase 2/3Results posted
• Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic CancerTerminatedNCT01851174Phase 2Results posted
• A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic AdenocarcinomaCompletedNCT01839799Phase 2Results posted
• Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic MelanomaCompletedNCT01827111Phase 2Results posted
• An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid TumorsTerminatedNCT01822756Phase 1Results posted
• Abraxane/BevacizumabTerminatedNCT01821859Phase 2Results posted
• Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLCCompletedNCT01757288Phase 1/2Results posted
• Schedules of Nab-Paclitaxel in Metastatic Breast CancerCompletedNCT01746225Phase 2Results posted
• Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerCompletedNCT01730833Phase 2Results posted
• Abraxane in CIMP-High Colorectal and Small Bowel AdenocarcinomasCompletedNCT01730586Phase 2Results posted
• Single Arm on the Tolerability of Weekly Nab-paclitaxelCompletedNCT01702844Phase 2Results posted
• Endoscopic Abraxane Injection Into Pancreatic CystsTerminatedNCT01698710Not applicableResults posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT01646762Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung CancerCompletedNCT01620190Phase 2Results posted
• Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck CancerCompletedNCT01566435Phase 2Results posted
• Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast CancerCompletedNCT01565499Phase 2Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerActive, not recruitingNCT01525966Phase 2Results posted
• Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic AdenocarcinomaCompletedNCT01470417Phase 2Results posted
• Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT01463072Phase 2Results posted
• Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)CompletedNCT01446016Phase 2Results posted
• Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT01412229Phase 2Results posted
• GSK1120212 Rollover StudyTerminatedNCT01376310Phase 2Results posted
• Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast CancerCompletedNCT01307891Phase 2Results posted
• Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast CancerTerminatedNCT01207102Phase 2Results posted
• Hedgehog Inhibitors for Metastatic Adenocarcinoma of the PancreasCompletedNCT01088815Phase 2Results posted
• Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerCompletedNCT01036087Phase 2Results posted
• Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial CancerTerminatedNCT00995488Phase 2Results posted
• Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 ExpressionCompletedNCT00944047Phase 2Results posted
• Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast CaTerminatedNCT00934895Phase 1/2Results posted
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant MelanomaCompletedNCT00864253Phase 3Results posted
• Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck CancerCompletedNCT00851877Phase 1/2Results posted
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the PancreasCompletedNCT00844649Phase 3Results posted
• Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck CancerCompletedNCT00833261Phase 2Results posted

← Albumin-Bound Paclitaxel overview